# Elicio Therapeutics, Inc.: Form 8-K, filed Dec 12, 2024

- Company: [Elicio Therapeutics, Inc.](/companies/eltx.md) (CIK 1601485)
- Form: 8-K
- Filed: 2024-12-12
- Accepted by EDGAR: Dec 12, 2024, 07:05 ET
- Period: 2024-12-12
- Accession: 0001601485-24-000107
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1601485/000160148524000107/angn-20241212.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1601485/000160148524000107/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1601485/000160148524000107/angn-20241212.htm

Filed Dec 12, 2024.
Source: SEC EDGAR, the filing index for accession 0001601485-24-000107. Last ingested by Listed: Nov 5, 2026, 17:56 ET. No prices; not investment advice.